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This  section  on  'EP  Update  -  Clinical'  summarizes  the  recent  literature  on  ventricular 
tachyarrhythmia and related  sudden cardiac death from leading journals.  The articles  have 
been hand picked and reviewed by the editors of IPEJ for the benefit of readers.          
Risk of sudden cardiac death in nonischemic dilated cardiomyopathy                   
Goldberger  JJ  and  colleagues  have  provided  a  meta  analysis  on  risk  stratification  for 
arrhythmic events in nonischemic dilated cardiomyopathy [1]. They identified 45 studies with 
over six thousand participants which looked at arrhythmic events and predictive tests [Table 
1].  They found that  the tests  of autonomic  variability  like heart  rate variability,  heart  rate 
turbulence  and  baroreflex  sensitivity  were  unable  to  predict  arrhythmic  outcomes  to  a 
significant extent. Other tests which include functional parameters, arrhythmic markers and 
depolarization / repolarization abnormalities have only a modest value in prediction of risk of 
sudden  cardiac  death  in  nonischemic  dilated  cardiomyopathy.  Authors  suggested  that  a 
combination  of  tests  will  be  needed  for  optimal  risk  prediction  in  nonischemic  dilated 
cardiomyopathy. This may be because multiple factors are involved in the pathogenesis of 
arrhythmia in nonischemic dilated cardiomyopathy, unlike in ischemic cardiomyopathy. Risk 
stratification  is  of  paramount  importance  on  deciding  who should receive  the  limited  and 
costly resource of an implantable cardioverter defibrillator. Ideally a good risk stratification 
method should give an odds ratio of more than 15, while most of the present risk stratification 
methods give an odds ration in the range of 2. It is also worth noting that most sudden cardiac 
deaths  occur  in  those  who  cannot  be  identified  by  current  risk  stratification  methods.  
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Table 1: Parameters evaluated for risk stratification
Evaluation of pediatric relatives of sudden arrhythmic death victims                    
Sudden arrhythmic deaths occur in the range of about one in a hundred thousand population. 
Identifying inherited cardiac conditions in this group will be of benefit to the family members 
in prevention of future catastrophes. Wong CH et al [2] looked at the data from two centers on 
pediatric  relatives  with  family  history  of  sudden  arrhythmic  deaths.  They  identified  112 
pediatric  relatives  from  61  families.  Of  the  evaluated  pediatric  relatives  6  had  inherited 
disorders and all of them were first degree relatives. Only 12 lead ECG, exercise testing and 
ajmaline provocation tests were found to be useful in the diagnosis of these inherited cardiac 
conditions. This was among an array of investigations including transthoracic echo, signal-
averaged ECG, Holter monitoring, exercise testing, cardiac magnetic resonance imaging and 
genetic  testing  when  indicated  as  per  clinical  guidelines.  In  this  study  samples  were  not 
available for molecular autopsy. Authors have also proposed a management pathway for these 
children. It may be noted that children without evidence of inherited cardiac disorders at initial 
evaluation  also  need  follow  up  as  all  disorders  may  not  manifest  at  young  age.  
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Higher  risk  of  ventricular  tachyarrhythmias  and  poor  reverse  remodeling  in  CRT 
patients  with  atrial  ventricular  ectopy                                 
It  is well  known that  highest percentage of biventricular  pacing is  optimal  for patients  on 
cardiac resynchronization therapy (CRT) for heart failure. Ruwal MH and associates [3] have 
studied  the  influence  of  atrial  and  ventricular  ectopic  beats  in  pre-implantation  Holter 
monitoring on the outcome of CRT as well as the potential for ventricular tachyarrhythmias. 
They noted that ectopic beats increase the chance of lower biventricular pacing, less reverse 
remodeling, higher risk of heart failure, death and ventricular tachyarrhythmias. We are aware 
that premature ventricular complexes (VPC) can cause or worsen heart failure. VPCs can also 
lower the probability of super response to CRT. Due to the abnormal sequence of activation, 
VPC  causes  dyssynchrony  by  itself.  PVC  by  inhibiting  a  paced  beat  can  reset  the  post 
ventricular atrial refractory period so that the next sinus beat may not be sensed and not trigger 
biventricular  pacing.  Atrial  premature  beats  can  be  associated  with  unrecognized  atrial 
fibrillation which can impair  CRT function due to the irregular  RR interval.  Irregular  RR 
intervals  can  also  increase  sympathetic  activity  and  enhance  the  chance  of  ventricular 
tachyarrhythmias  and  cardiac  arrest.                                       
Early  recurrence  of  ventricular  tachycardia  after  catheter  ablation  in  those  with 
structural  heart  disease                              
Ventricular tachycardia (VT) associated with structural heart disease is often difficult to treat  
by  catheter  ablation.  Recurrence  of  arrhythmia  after  ablation  is  associated  with  increased 
mortality. Nagashima K et al [4] found that one fifth of patients undergoing catheter ablation 
of VT in association with structural heart disease have an early recurrence within a week, most 
of it being in the first two days. Early recurrence of VT increased the long term mortality risk 
more than two and a half times. Programmed stimulation after ablation had limited role in 
prediction of recurrence as more than two third of those with inducible VT at the end of the 
procedure had no recurrence. But more than half of those who had a recurrence had inducible 
VT at  the end of the procedure.  On the other  hand 17% of the 211 patients  who had no 
inducible VT at the conclusion of the ablation procedure had early recurrence of VT. This is 
attributed to healing of the ablation lesions. VT morphology was similar to that of the initial 
clinical  VT in half  of the recurrences.  Reduction of  antiarrhythmic  drug dose might  have 
contributed to  recurrence in 40% of the early recurrences.  Early recurrence  of VT was in 
independent  predictor  of  mortality  even  in  the  presence  of  an  implantable  cardioverter 
defibrillator (ICD). Recurrent VT could be slower, below the detection threshold rate of the 
ICD and cause aggravation of heart failure. Those selected for a repeat ablation tended to be 
more  sick  and  likely  to  develop  VT  storm.                             
Justification  of  Class  II  indication for  ICD in  Brugada syndrome in  Japanese  study
Spontaneous type 1 Brugada ECG with history of syncope likely to  be due to ventricular 
tachyarrhytmia  is  a  Class  IIa  indication  for  the  implantation  of  an  ICD  as  per 
HRS/EHRA/APHRS Expert Consensus Statement 2013. Class IIb recommendation for ICD 
implantation was given for those with either a spontaneous or drug induced type 1 Brugada 
ECG  and  inducible  ventricular  fibrillation  (VF)  on  programmed  electrical  stimulation.  A 
Japanese multicenter study [5] has further validated these Class II indications by evaluating 
over two hundred patients with Brugada syndrome and these features. These were Brugada 
syndrome patients without a previous cardiac arrest. It was noted during follow up that cardiac 
events occurred more often in those with Class IIa indication than in those with Class IIb 
indication.  This  is  presumably  because  syncope  considered  to  be  due  to  ventricular 
tachyarrhythmia has been recognized as in important risk factor for fast VT, VF and sudden 
cardiac  death  in  several  studies.  In  the  present  study,  Class  IIa  indication  conferred  an 
intermediate risk of cardiac events, 2.2% per year while Class IIb indication carried a risk of 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 14 (6): 316-319   (2014)
Francis J et al, “Update on Ventricular Tachyarrhythmias and Related SCD”                 319
only  0.5%  per  year.                                          
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